Lilly not responsible for Zyprexa user’s death, jury finds
It’s the first verdict in a Zyprexa case since litigation over the antipsychotic drug, the drugmaker’s top seller, began more than eight years ago.
Bloomberg News
Articles
Biggest losers in NFL see bargain opportunity in Luck
The winless Indianapolis Colts and Miami Dolphins are jockeying to land what one former National Football League executive says may be the most valuable—and reasonably priced—top pick in modern draft history.
Lilly hid Zyprexa’s diabetes risks, family’s lawyer argues
Eli Lilly and Co. hid the diabetes risks of Zyprexa to protect sales, a lawyer for the family of a 20-year-old patient who died while taking the medicine told a jury in the first case to go to trial over the drug. The attorney asked jurors to award the family $40 million in compensatory damages.
Lilly loses British Supreme Court ruling over gene patent
The British Supreme Court ruled in favor of Human Genome Sciences Inc. in its dispute with Eli Lilly and Co. over the validity of a patent for a gene sequence that could be used to treat people with immune diseases.
Ener1 becomes latest energy aid recipient in trouble
Electric-car battery maker Ener1 Inc., whose shares were delisted from the NASDAQ stock market Oct. 28, is the latest recipient of U.S. Energy Department aid to run into financial trouble and draw congressional scrutiny.
Confident automakers adding factory workers
Plants in Indiana and other states are slowly expanding as car companies foresee improved sales due to pent-up demand, population growth and an aging vehicle fleet.
BorgWarner sues Cummins over patents on turbochargers
BorgWarner Inc., the world’s biggest maker of automatic-transmission parts for vehicles, filed a lawsuit accusing Cummins Inc. of infringing on three patents for a titanium wheel used in engine turbochargers.
Lilly pulls Xigris off market after sepsis drug fails study
Eli Lilly and Co. said it will pull its Xigris sepsis drug from all markets after the treatment failed to reduce mortality in a study. The withdrawal may cost Lilly $75 million to $95 million in the fourth quarter.
Simon boosts forecast as quarterly results exceed expectations
Indianapolis-based shopping mall giant Simon Property Group Inc. reported funds from operations that beat analyst estimates and raised its full-year forecast as income from rents rose.
Pacer Foster earns reputation as Buffett of basketball
Indiana Pacer Jeff Foster has played in the NBA for 12 years and earned more than $47 million, and he’s done something extraordinary: He’s saved about three-quarters of his take-home pay.
Lilly diabetes drug wins approval for expanded use
Eli Lilly and Co. and Amylin Pharmaceuticals Inc.’s Byetta has received expanded approval for use with the world’s top-selling insulin to treat Type 2 diabetes.
Farm plan may preserve crop subsidies, groups say
A bill backed by Indiana Sen. Richard Lugar would consolidate several subsidy programs into a plan to aid farmers when revenue declines.
Cook Medical gets FDA panel’s backing for stent
The device would be the first drug-coated stent approved in the U.S. to treat peripheral vascular disease in the largest artery of the upper leg.
FDA: Cook Medical’s stent met efficacy, safety goals
Peripheral vascular devices, including stents, angioplasty balloons and synthetic grafts, generated $4.3 billion in global revenue last year and may earn $5.6 billion in 2014.
Cummins needs to hire 7,000 engineers, CEO says
Columbus-based engine maker Cummins Inc. needs to add 7,000 engineers within five years, CEO Theodore Solso said Wednesday.
Lilly CEO says he’s not interested in Pfizer animal unit
Drugmaker Eli Lilly and Co. doesn’t plan to buy Pfizer Inc.’s $3.58 billion animal-health business, CEO John Lechleiter said Wednesday.
Election spending to exceed $6B thanks to Indiana lawyer
Indiana attorney James Bopp Jr. has spent 30 years fighting limits on campaign spending, and next year’s political landscape could be transformed by his labor.
Farm subsidies may face cuts amid record profits
U.S. farmers earning record profits are fighting to maintain agricultural subsidies, a likely target of the congressional supercommittee working to reduce federal spending.
Eli Lilly, Turkish firm in talks to sell drugs in 26 nations
Eli Lilly and Co., the world’s biggest maker of psychiatric drugs, is in talks with Mustafa Nevzat Ilac Sanayii AS to sell the Turkish company’s treatments in 26 countries, said Mustafa Nevzat’s CEO.
WellPoint expands share buyback plan by $5 billion
The insurer said it will use the authorization over several years as market and industry conditions dictate.